No Data
No Data
No Data
No Data
No Data
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free cas
BenzingaApr 9 13:12 ET
Inozyme Pharma Is Maintained at Buy by B of A Securities
Inozyme Pharma Is Maintained at Buy by B of A Securities
Dow JonesApr 9 12:47 ET
B of A Securities Maintains Buy on Inozyme Pharma, Lowers Price Target to $14
B of A Securities analyst Tazeen Ahmad maintains Inozyme Pharma with a Buy and lowers the price target from $16 to $14.
Analyst UpgradesApr 9 12:38 ET
Express News | Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target
Moomoo 24/7Apr 9 07:56 ET
Inozyme Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/09/2024 298.61% Needham → $23 Reiterates Buy → Buy 03/13/2024 177.3% HC Wainwright & Co. $16 → $16 Main
BenzingaApr 9 07:53 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Zai Lab (ZLAB) and Idexx Laboratories (IDXX)
TipRanksApr 9 06:20 ET
No Data
No Data
全力買い : バイオおすすめありますか?